[go: up one dir, main page]

FI952721L - Aine maksa-sappi-sairauksien hoitamiseksi - Google Patents

Aine maksa-sappi-sairauksien hoitamiseksi Download PDF

Info

Publication number
FI952721L
FI952721L FI952721A FI952721A FI952721L FI 952721 L FI952721 L FI 952721L FI 952721 A FI952721 A FI 952721A FI 952721 A FI952721 A FI 952721A FI 952721 L FI952721 L FI 952721L
Authority
FI
Finland
Prior art keywords
substance
treatment
hepatobiliary diseases
hepatobiliary
diseases
Prior art date
Application number
FI952721A
Other languages
English (en)
Swedish (sv)
Other versions
FI952721A7 (fi
FI952721A0 (fi
Inventor
Ryuji Ueno
Original Assignee
R Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R Tech Ueno Ltd filed Critical R Tech Ueno Ltd
Publication of FI952721A0 publication Critical patent/FI952721A0/fi
Publication of FI952721A7 publication Critical patent/FI952721A7/fi
Publication of FI952721L publication Critical patent/FI952721L/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI952721A 1994-06-03 1995-06-02 Aine maksa-sappi-sairauksien hoitamiseksi FI952721L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP12248794 1994-06-03

Publications (3)

Publication Number Publication Date
FI952721A0 FI952721A0 (fi) 1995-06-02
FI952721A7 FI952721A7 (fi) 1995-12-04
FI952721L true FI952721L (fi) 1995-12-04

Family

ID=14837070

Family Applications (1)

Application Number Title Priority Date Filing Date
FI952721A FI952721L (fi) 1994-06-03 1995-06-02 Aine maksa-sappi-sairauksien hoitamiseksi

Country Status (14)

Country Link
US (1) US5739161A (fi)
EP (1) EP0690049B1 (fi)
KR (1) KR100260573B1 (fi)
CN (1) CN1076605C (fi)
AT (1) ATE182884T1 (fi)
AU (1) AU690241B2 (fi)
CA (1) CA2150287C (fi)
DE (1) DE69511181T2 (fi)
DK (1) DK0690049T3 (fi)
ES (1) ES2137456T3 (fi)
FI (1) FI952721L (fi)
GR (1) GR3031066T3 (fi)
NO (1) NO308993B1 (fi)
NZ (1) NZ272234A (fi)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE29717252U1 (de) * 1997-09-26 1998-02-19 Dr. Falk Pharma GmbH, 79108 Freiburg Arzneimittelkit aus einem Budesonid-haltigen und einem Ursodesoxycholsäure-haltigen Arzneimittel zur Behandlung von cholestatischen Lebererkrankungen
CA2274670C (en) * 1997-10-13 2011-04-12 R-Tech Ueno, Ltd. 15-keto prostaglandins as portal hypertension inhibitors
TWI225398B (en) 1999-07-14 2004-12-21 R Tech Ueno Ltd Composition for treatment of external secretion disorders
HK1045693B (en) 1999-10-15 2005-01-21 Sucampo Ag Bicyclic compounds composition and method for stabilizing the same
KR100788226B1 (ko) 2000-03-24 2007-12-26 수캄포 아게 15-케토-프로스타글란딘 또는 이의 유도체를 포함하는세포자연사 억제 조성물
WO2001076593A2 (en) 2000-04-06 2001-10-18 Sucampo Ag Bile secretion promoting composition a 15-keto prostaglandin
US6414016B1 (en) 2000-09-05 2002-07-02 Sucampo, A.G. Anti-constipation composition
TWI302100B (en) 2001-05-02 2008-10-21 Sucampo Ag Composition for treating drug-induced constipation
WO2003030912A1 (en) 2001-08-31 2003-04-17 Sucampo Ag Prostaglandin analogs as chloride channel opener
AR037524A1 (es) * 2001-11-14 2004-11-17 Sucampo Ag Unidad de dosificacion que comprende un analogo de prostaglandina para el tratamiento de la constipacion
US7732487B2 (en) * 2001-11-19 2010-06-08 Sucampo Ag Method for treating a disease or condition responsive to opening of C1C-2 channel
ES2379652T3 (es) * 2002-10-23 2012-04-30 Sucampo Ag Compuestos de prostaglandina para el tratamiento de obesidad
AU2003292556B2 (en) 2002-12-27 2009-09-10 Sucampo Ag Derivatives of prostaglandins for treating abdominal discomfort
ATE489096T1 (de) * 2003-07-03 2010-12-15 Sucampo Ag Pharmazeutische magensaftresistent überzogene zusammensetzung enthaltend prostaglandin-analoga als chloridkanalöffner
KR20120005052A (ko) 2003-08-21 2012-01-13 수캄포 아게 안과용 조성물
JP4690814B2 (ja) * 2004-08-02 2011-06-01 株式会社アールテック・ウエノ プロスタグランジン誘導体の製造法
TWI384988B (zh) * 2005-01-27 2013-02-11 Sucampo Ag 處理中樞神經系統失常用之組成物
TW201410248A (zh) 2005-03-04 2014-03-16 Sucampo Ag 處理週邊血管疾患之方法及組成物
US20060281818A1 (en) 2005-03-21 2006-12-14 Sucampo Ag, North Carolina State University Method for treating mucosal disorders
CN101198334B (zh) * 2005-04-12 2013-02-06 苏坎波公司 前列腺素化合物和质子泵抑制剂用于治疗肠胃病的联合应用
AU2007208632B2 (en) * 2006-01-24 2012-01-19 R-Tech Ueno, Ltd. Soft-gelatin capsule formulation
EP2682130A1 (en) * 2006-01-24 2014-01-08 R-Tech Ueno, Ltd. Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cyclic compound
JP4648340B2 (ja) * 2006-02-07 2011-03-09 株式会社アールテック・ウエノ １５−ケトプロスタグランジンｅ誘導体の製造法
CA2819844C (en) * 2006-02-07 2015-09-15 R-Tech Ueno, Ltd. Prostaglandin derivatives
NZ571092A (en) * 2006-02-28 2010-11-26 Sucampo Ag Method and composition for treating chronic obstructive pulmonary disease
CN104224704A (zh) 2006-03-13 2014-12-24 株式会社·R-技术上野 水性组合物
US8871752B2 (en) 2008-02-19 2014-10-28 Sucampo Ag Method for modulating stem cell growth
US8609729B2 (en) 2009-04-15 2013-12-17 Sucampo Ag Method for treating macular degeneration
US8569279B2 (en) * 2009-05-27 2013-10-29 Sucampo Ag Method for modulating claudin mediated functions
US20110034424A1 (en) * 2009-06-30 2011-02-10 Sucampo Ag Method for the long term nsaid use
US9084815B2 (en) * 2009-09-16 2015-07-21 Sucampo Ag Method for treating damage induced by an anti-tumor agent, treating mucositis and treating tumor
TW201247206A (en) 2011-04-07 2012-12-01 Sucampo Ag Method for treating asthenopia
JP2014511825A (ja) * 2011-04-19 2014-05-19 スキャンポ・アーゲー サイトカイン活性の調節方法
CN103764639B (zh) * 2011-07-01 2016-04-13 株式会社·R-技术上野 用于制备脂肪酸衍生物的方法
CN102875586A (zh) * 2011-07-11 2013-01-16 上海天伟生物制药有限公司 一种利马前列素关键中间体的制备方法
TWI619497B (zh) 2011-08-05 2018-04-01 Sucampo Ag 精神分裂症的處置方法
CN103058907B (zh) * 2011-10-21 2016-05-11 武汉启瑞药业有限公司 鲁比前列酮或其中间体的制备方法
AR092821A1 (es) 2012-04-20 2015-05-06 Sucampo Ag Conjugado de derivado de acido graso-polimero
US20150057351A1 (en) 2013-08-22 2015-02-26 Sucampo Ag Method for treating neuropathic pain
WO2016203317A1 (en) 2015-06-19 2016-12-22 Sucampo Ag Pharmaceutical compositions comprising fatty acid derivative
US10428566B2 (en) * 2017-04-17 2019-10-01 James G. Arendts Flexible unitary sandwich-like panel overhead door

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4306078A (en) * 1979-12-03 1981-12-15 Hoffmann-La Roche Inc. 16-Substituted prostaglandins
US4374856A (en) 1980-09-10 1983-02-22 The Upjohn Company Liver cytoprotection using PGE's
JPS58164512A (ja) 1982-03-25 1983-09-29 Ono Pharmaceut Co Ltd プロスタグランジン類似化合物を有効成分として含有する肝臓疾患治療剤
JPS58203911A (ja) 1982-05-25 1983-11-28 Ono Pharmaceut Co Ltd プロスタグランジン類似化合物を有効成分として含有する細肪障害治療剤
JPS62129218A (ja) 1985-12-02 1987-06-11 Teijin Ltd チアプロスタグランジン類を活性成分として含有する肝疾患治療剤
CA1323364C (en) 1987-01-28 1993-10-19 Ryuzo Ueno Prostaglandins e and anti ulcer agents containing same
US5166174A (en) * 1987-01-28 1992-11-24 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti-ulcers containing same
JPH0688966B2 (ja) 1987-01-28 1994-11-09 株式会社アールテック・ウエノ プロスタグランジンｅ類およびそれを含む抗潰瘍剤
JPH0681728B2 (ja) 1987-10-02 1994-10-19 株式会社上野製薬応用研究所 下 剤
EP0310305B1 (en) 1987-10-02 1992-07-22 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Cathartics
JP2579193B2 (ja) 1988-07-19 1997-02-05 小野薬品工業株式会社 １６，１６−ジフルオロ−１５−オキソ−１５−デオキシｐｇｅ誘導体
DD295522A5 (de) * 1989-07-26 1991-11-07 �����@������������������k�� 5-Alkyl-1,3,4-Thiadiazole, Verfahren zu ihrer Herstellung und Verwendung als Schädlingsbekämpfungsmittel
CA2027814C (en) * 1989-10-20 1996-07-30 Ryuji Ueno Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds

Also Published As

Publication number Publication date
FI952721A7 (fi) 1995-12-04
NO308993B1 (no) 2000-11-27
CA2150287A1 (en) 1995-12-04
AU2041295A (en) 1995-12-14
NZ272234A (en) 1996-02-27
NO952214D0 (no) 1995-06-02
ES2137456T3 (es) 1999-12-16
US5739161A (en) 1998-04-14
KR960000230A (ko) 1996-01-25
CN1076605C (zh) 2001-12-26
GR3031066T3 (en) 1999-12-31
ATE182884T1 (de) 1999-08-15
EP0690049A2 (en) 1996-01-03
DK0690049T3 (da) 2000-03-06
AU690241B2 (en) 1998-04-23
DE69511181D1 (de) 1999-09-09
KR100260573B1 (ko) 2000-07-01
CN1126591A (zh) 1996-07-17
NO952214L (no) 1995-12-04
EP0690049B1 (en) 1999-08-04
FI952721A0 (fi) 1995-06-02
EP0690049A3 (en) 1997-03-26
DE69511181T2 (de) 1999-12-02
CA2150287C (en) 2004-08-10

Similar Documents

Publication Publication Date Title
FI952721A7 (fi) Aine maksa-sappi-sairauksien hoitamiseksi
NO976063D0 (no) Fremgangsmåte for behandling av diabetes
NO952573D0 (no) Blandinger for behandling av diabetiske komplikasjoner
FI963696A7 (fi) Geeli ihosairauksien hoitoon ja ihon desinfiointiin
ATE308527T1 (de) Phenylamino-substituierte triicyclische derivate zur behandlung hyperproliferativer krankheiten
FI973292A7 (fi) Substituoituja isoksatsoleja tulehduksen hoitamiseksi
DK0769017T3 (da) Terapeutiske forbindelser
DE69524138D1 (de) Hautbehandlungsmittel
NO991459L (no) Anvendelse av 1-hydroksy-2-pyridoner til behandling av hudinfeksjoner
DE69807466D1 (de) Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten
FI971527L (fi) Indolijohdannaisten käyttö erilaisten sairauksien hoitoon
DE69822297D1 (de) Triptolid-derivate geeignet zur behandlung von autoimmunkrankheiten
EE03437B1 (et) Benseenamiidid neurodegeneratiivsete haiguste ravimiseks
NO913117L (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
NO981822L (no) Anvendelse av proteinet GAX for behandling av cancer
FI963264A7 (fi) Tromboksaani A2-välitteisten sairauksien ennaltaestoon ja hoitoon tarkoitettu aine
NO982562D0 (no) Sammensetning for behandling av smerte
NO973366D0 (no) Fremgangsmåte for behandling av multippel sklerose
DE69529295D1 (de) Chemische proteindenaturierungsbehandlung
DE69840432D1 (de) Arzneimittel zur behandlung der augen
FI952953L (fi) Aineita metabolisten luustosairauksien hoitamiseen
ATE235494T1 (de) Imino-aza-anthracyclonderivate zur behandlung von amyloidosis
NO20002481D0 (no) Kombinasjonsterapi for behandling av AIDS
ID24439A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia
UA25833C2 (uk) Засіб для лікуваhhя мелаhомобластом